A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants
Abstract Individuals with Lynch syndrome (LS), have an increased risk of developing cancer. Common genetic variants of telomerase reverse transcriptase (TERT) have been associated with a wide range of cancers, including colorectal cancer (CRC) in LS. We combined genotype data from 1881 LS patients,...
Guardado en:
Autores principales: | Mariann Unhjem Wiik, Tiffany-Jane Evans, Sami Belhadj, Katherine A. Bolton, Dagmara Dymerska, Shantie Jagmohan-Changur, Gabriel Capellá, Grzegorz Kurzawski, Juul T. Wijnen, Laura Valle, Hans F. A. Vasen, Jan Lubinski, Rodney J. Scott, Bente A. Talseth-Palmer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57328817e3ef4af195d6762ecb741f15 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Frequency and variability of genomic rearrangements on MSH2 in Spanish Lynch Syndrome families.
por: Atocha Romero, et al.
Publicado: (2013) -
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2
por: Sigurdis Haraldsdottir, et al.
Publicado: (2017) -
Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells
por: Zhengpei Zhang, et al.
Publicado: (2017) -
Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
por: Yoon Young Choi, et al.
Publicado: (2021) -
Telomerase reverse transcriptase synergizes with calorie restriction to increase health span and extend mouse longevity.
por: Elsa Vera, et al.
Publicado: (2013)